Shibutani Masatsune, Maeda Kiyoshi, Nagahara Hisashi, Noda Eiji, Ohtani Hiroshi, Sugano Kenji, Takii Mamiko, Kimura Kenjiro, Toyokawa Takahiro, Amano Ryosuke, Kubo Naoshi, Tanaka Hiroaki, Muguruma Kazuya, Ohira Masaichi, Hirakawa Kosei
Dept. of Surgical Oncology, Osaka City University Graduate School of Medicine.
Gan To Kagaku Ryoho. 2013 Nov;40(12):1603-5.
This study aimed to investigate the clinical significance of preoperative neutrophil-to-lymphocyte ratio(NLR)as a predictor of prognosis in patients with Stage IV colorectal cancer. A total of 130 patients who underwent operation for Stage IV colorectal cancer were enrolled in the study. Of the patients, 69 had an NLR of ≥ 3.0 and were defined as the high-NLR group. Patients who received preoperative therapy and underwent emergency operation for perforation were excluded from the analysis. The 2-year survival rate was 58.1% in the high-NLR group and 43.5% in the low-NLR group. The median survival time was 38.0 months in the high-NLR group and 22.3 months in the low-NLR group. The patient prognosis in the high-NLR group was significantly worse than that in the low-NLR group. A univariate analysis indicated that high NLR, peritoneal dissemination, curability C, histological type( non-differentiated), and number of organs involved in metastasis (more than 1 organ) were the risk factors of poor survival. All of these factors, except peritoneal dissemination, were independent risk factors for poor survival on multivariate analysis. A high preoperative NLR may be considered as a convenient biomarker to identify patients with a poor prognosis after operation for stage IV colorectal cancer.
本研究旨在探讨术前中性粒细胞与淋巴细胞比值(NLR)作为预测IV期结直肠癌患者预后指标的临床意义。共有130例行IV期结直肠癌手术的患者纳入本研究。其中,69例患者的NLR≥3.0,被定义为高NLR组。接受术前治疗及因穿孔行急诊手术的患者被排除在分析之外。高NLR组的2年生存率为58.1%,低NLR组为43.5%。高NLR组的中位生存时间为38.0个月,低NLR组为22.3个月。高NLR组患者的预后明显差于低NLR组。单因素分析表明,高NLR、腹膜播散、可切除性C、组织学类型(未分化)及转移累及器官数量(超过1个器官)是生存不良的危险因素。多因素分析显示,除腹膜播散外,所有这些因素均为生存不良的独立危险因素。术前高NLR可被视为一种简便的生物标志物,用于识别IV期结直肠癌术后预后不良的患者。